WuXi Biologics Stock Price
Live from Yahoo Finance · auto-updates · ≈15 min delayed
2269 is trading 10.2% below its 52-week high and sits in the upper third of its 52-week range (79% of the way from low to high).
2269 price chart
Why 2269 is on our radar
Global biologics outsourcing; drug pipeline leverage
Latest 2269 news
- WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwindsscmp.com
- Citi Raises Target Prices for WuXi Biologics and WuXi XDC on Order Momentum and Margin Recoveryfinance.biggo.com
- WuXi Biologics: Revenue up 18.4% and gross margin at 46.2%, with strong growth in new modalities and raised guidancetradingview.com
- WuXi Biologics Appoints Lori Spector as Head of Human Resources – North Americahrtoday.in
- WuXi Biologics: H1 2026 revenue up 23.4% YoY in USD, with margin expansion and robust project growthtradingview.com
Headlines via Google News. Rates.my is not affiliated with these publishers.
WuXi Biologics — key facts
Not financial advice. Prices are indicative and may be delayed. Nothing on this page is a buy or sell recommendation. Rates.my is an independent information site — not a broker or licensed adviser. We don't hold WuXi Biologics; every position Rates.my does hold is disclosed on our Smart Money page. Always verify on a live source and do your own research.
Related stocks
2269 discussion & reviews
What do you think about WuXi Biologics? Share your view, target or question — no sign-up needed.